156 related articles for article (PubMed ID: 31302615)
1. Nasal mucosal melanoma as a cause of epistaxis.
Behranwala R; Loku Waduge BH; Teo B
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31302615
[TBL] [Abstract][Full Text] [Related]
2. Recurrent epistaxis leading to diagnosis of primary sinonasal melanoma.
Tawagi K; Akaraz-Avedissian R; Burman-Solovyeva I
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29453209
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance features of sinonasal melanotic mucosal melanoma.
Nardi C; Vignoli C; Vannucchi M; Pietragalla M
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31337627
[TBL] [Abstract][Full Text] [Related]
4. Dramatic effect of nivolumab against melanoma and immune-related liver toxicity: A detailed histopathological and immunohistochemical analysis of nivolumab-induced liver toxicity.
Namiki T; Nojima K; Chikazawa S; Iwamoto Y; Otsuki Y; Albusani H; Miura K; Kiyokawa Y; Asakage T; Yokozeki H
J Dermatol; 2019 May; 46(5):e182-e183. PubMed ID: 30474878
[No Abstract] [Full Text] [Related]
5. Mucosal melanoma of the nasal cavity and paranasal sinuses.
Gilain L; Houette A; Montalban A; Mom T; Saroul N
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):365-369. PubMed ID: 24906226
[TBL] [Abstract][Full Text] [Related]
6. Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.
Ascierto PA; Vanella V; Grimaldi AM; Lucia F; Palla M; Simeone E; Mozzillo N
Cancer Immunol Immunother; 2016 Nov; 65(11):1395-1400. PubMed ID: 27604993
[TBL] [Abstract][Full Text] [Related]
7. Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.
Philipp M; Frischhut N; Tschachler A; Steinkohl F; Weinlich G; Schmuth M; Nguyen VA
Anticancer Drugs; 2018 Oct; 29(9):914-918. PubMed ID: 29952773
[TBL] [Abstract][Full Text] [Related]
8. Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.
Maekawa T; Okada K; Okada H; Kado S; Kamiya K; Komine M; Murata S; Oka K; Ishibashi S; Ohtsuki M
J Dermatol; 2019 Dec; 46(12):e463-e464. PubMed ID: 31436330
[No Abstract] [Full Text] [Related]
9. Primary malignant melanoma of the nose: a rare cause of epistaxis in the elderly.
Tiwari D; Plater M; Partridge R; Weston-Simons J
Age Ageing; 2005 Nov; 34(6):653-4. PubMed ID: 16267199
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Hodi FS; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Cowey CL; Lao CD; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Hill A; Hogg D; Marquez-Rodas I; Jiang J; Rizzo J; Larkin J; Wolchok JD
Lancet Oncol; 2018 Nov; 19(11):1480-1492. PubMed ID: 30361170
[TBL] [Abstract][Full Text] [Related]
11. Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who Initially Had a Progression on T-VEC With Pembrolizumab.
Afzal MZ; Shirai K
J Immunother; 2019 May; 42(4):136-141. PubMed ID: 30933044
[TBL] [Abstract][Full Text] [Related]
12. Mucosal melanoma of the sinonasal tract.
Ferraro RE; Schweinfurth JM; Highfill GR
Am J Otolaryngol; 2002; 23(5):321-3. PubMed ID: 12239703
[TBL] [Abstract][Full Text] [Related]
13. [Primary malignant melanoma of the nasal mucosa with orbital involvement. Case report].
Gallotti M; Gencarelli G; Lancella A; Perinti A
Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):248-51. PubMed ID: 12379047
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
15. Malignant mucosal melanoma in the nasal cavity: an uncommon cause of epistaxis.
Lo RH; Chang KP; Chu ST
J Chin Med Assoc; 2010 Sep; 73(9):496-8. PubMed ID: 20875625
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Zimmer L; Livingstone E; Hassel JC; Fluck M; Eigentler T; Loquai C; Haferkamp S; Gutzmer R; Meier F; Mohr P; Hauschild A; Schilling B; Menzer C; Kieker F; Dippel E; Rösch A; Simon JC; Conrad B; Körner S; Windemuth-Kieselbach C; Schwarz L; Garbe C; Becker JC; Schadendorf D;
Lancet; 2020 May; 395(10236):1558-1568. PubMed ID: 32416781
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.
Namikawa K; Kiyohara Y; Takenouchi T; Uhara H; Uchi H; Yoshikawa S; Takatsuka S; Koga H; Wada N; Minami H; Hatsumichi M; Asada S; Namba Y; Yamazaki N
Eur J Cancer; 2018 Dec; 105():114-126. PubMed ID: 30447539
[TBL] [Abstract][Full Text] [Related]
18. [Three cases of mucosal malignant melanoma of the nose and paranasal sinuses].
Kaymakçi M; Gür OE; Aygenç E; Fidan F; Ozdem C
Kulak Burun Bogaz Ihtis Derg; 2005; 15(3-4):87-90. PubMed ID: 16340299
[TBL] [Abstract][Full Text] [Related]
19. [Haemangiopericytoma of the nasal cavity as a cause of recurrent epistaxis--case report].
Kuzniar J; Pazdro-Zastawny K; Sztuka A; Rostkowska-Nadolska B; Jeleń M
Pol Merkur Lekarski; 2006 Jul; 21(121):65-8. PubMed ID: 17007297
[TBL] [Abstract][Full Text] [Related]
20. Primary mucosal melanoma of the nasal cavity: an uncommon cause of epistaxis in the elderly.
Ferri E; Pavon I; Armato E; Ianniello F
Otolaryngol Head Neck Surg; 2008 Jun; 138(6):797-8. PubMed ID: 18503860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
